Clinical Trials
5
Active:4
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 3
1 (50.0%)Efficacy and Safety of the Pain Relieving Effect of Dronabinol in Central Neuropathic Pain Related to Multiple Sclerosis
Phase 3
Completed
- Conditions
- Central Neuropathic Pain in Multiple Sclerosis
- Interventions
- Drug: Placebo
- First Posted Date
- 2009-08-14
- Last Posted Date
- 2012-02-03
- Lead Sponsor
- Bionorica Research GmbH
- Target Recruit Count
- 240
- Registration Number
- NCT00959218
- Locations
- 🇩🇪
Maerkische Kliniken GmbH, Klinikum Luedenscheid, Akademisches Lehrkrankenhaus der Universitaet Bonn, Klinik fuer Neurologie, Luedenscheid, Germany
News
No news found